Doxercalciferol

度骨化醇

Report date: 2025/09/27 20:00:08
NME

Base Information

Drug NameDoxercalciferol
Drug Alias NameDoxercalciferolumRedisparHectorol1alpha-D2TSA-840 +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVitamin D2 analoguesVitamin D receptor agonists
TargetsVitamin D receptor
Therapy Area/IndicationsPlaque psoriasisSolid tumoursHyperparathyroidism, Secondary +[7] 
Global Approved IndicationsHyperparathyroidism, Secondary
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1999/06/09
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesGenzyme Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofiUniversity Of Wisconsin-MadisonThe University Of Texas MD Anderson Cancer Center +[4] 
Active IndicationsN/A
Inactive IndicationsPlaque psoriasisSolid tumoursHyperparathyroidism, Secondary +[7] 

Other Information

ATC CodeH05BX03
Related LinksWikipediaDrugBankKEGG